Table 5.
Characteristics of study participants.
| Characteristics | Controls (n = 140) | MS (n = 142) |
|---|---|---|
| Gender | ||
| Male | 51 (36%) | 67 (47%) |
| Female | 89 (64%) | 75 (53%) |
| Age (mean ± SD) | 45 ± 12 | 53 ± 14 |
| BMI (kg/m2) | ||
| Underweight (≤ 18.5) | 22.2 ± 2.45 | 19.45 ± 4.67 |
| Normal weight (18.5–24.9) | ||
| Overweight (25–29.9) | ||
| Obesity (≥ 30) | ||
| Mean disease duration (years) | N/A | 14.5 ± 8.1 |
| EDSS | ||
| From normal to mid disability (1.0–4.5) | N/A | 5.5. ± 1.9 |
| From moderate to severe disability (5.0–9.5) | ||
| Death due to MS (10.0) | ||
| MMSE | ||
| Normal (25–30) | N/A | 23.79 ± 6 |
| Mild impairment (21–24) | ||
| Moderate impairment (10–20) | ||
| Severe impairment (≤ 9) | ||
| BDI | ||
| Normal (≤ 9) | N/A | 10 ± 4 |
| Minimal depressive symptomatology (10–15) | ||
| Mild depression (16–31) | ||
| Moderate depression (32–47) | ||
| Severe depression (≥ 47) | ||
| GDS | ||
| Normal (0–4) | N/A | 7.5 ± 4.56 |
| Mild depression (5–8) | ||
| Moderate depression (9–11) | ||
| Severe depression (12–15) | ||
N/A not applicable.